blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3116879

EP3116879 - IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  28.06.2019
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  16.03.2018
FormerRequest for examination was made
Status updated on  16.12.2016
FormerThe international publication has been made
Status updated on  16.11.2016
Most recent event   Tooltip28.06.2019Application deemed to be withdrawnpublished on 31.07.2019  [2019/31]
Applicant(s)For all designated states
VIIV Healthcare UK (No.5) Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
[2017/03]
Inventor(s)01 / NAIDU, B. Narasimhulu
c/o Bristol-Myers Squibb Company
5 Research Parkway
Wallingford, Connecticut 06492 / US
02 / PATEL, Manoj
c/o Bristol-Myers Squibb Company
5 Research Parkway
llingford, Connecticut 06492 / US
 [2017/03]
Representative(s)Learoyd, Stephanie Anne
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
[2017/03]
Application number, filing date15708065.613.02.2015
[2017/03]
WO2015US15895
Priority number, dateUS201461940912P18.02.2014         Original published format: US 201461940912 P
[2017/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015126758
Date:27.08.2015
Language:EN
[2015/34]
Type: A1 Application with search report 
No.:EP3116879
Date:18.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 27.08.2015 takes the place of the publication of the European patent application.
[2017/03]
Search report(s)International search report - published on:EP27.08.2015
ClassificationIPC:C07D498/22, A61K31/529, A61P31/18
[2017/03]
CPC:
C07D498/22 (EP,US); A61K31/529 (EP,US); A61K45/06 (US);
A61P31/18 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/03]
Extension statesBA13.09.2016
ME13.09.2016
TitleGerman:IMIDAZOPYRIMIDIN-MAKROCYCLEN ALS INHIBITOREN DER REPLIKATION DES MENSCHLICHEN IMMUNSCHWÄCHEVIRUS[2017/03]
English:IMIDAZOPYRIMIDINE MACROCYCLES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION[2017/03]
French:MACROCYCLES D'IMIDAZOPYRIMIDINE UTILISÉS COMME INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE[2017/03]
Entry into regional phase13.09.2016National basic fee paid 
13.09.2016Designation fee(s) paid 
13.09.2016Examination fee paid 
Examination procedure13.09.2016Amendment by applicant (claims and/or description)
13.09.2016Examination requested  [2017/03]
13.09.2016Date on which the examining division has become responsible
16.03.2018Despatch of a communication from the examining division (Time limit: M04)
14.05.2018Reply to a communication from the examining division
16.08.2018Despatch of a communication from the examining division (Time limit: M06)
27.02.2019Application deemed to be withdrawn, date of legal effect  [2019/31]
26.03.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/31]
Fees paidRenewal fee
07.02.2017Renewal fee patent year 03
07.02.2018Renewal fee patent year 04
08.02.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[AD]WO2012065963  (UNIV LEUVEN KATH [BE], et al);
 [AD]US2013231331  (PENDRI ANNAPURNA [US], et al);
 [IDP]US2014051692  (NAIDU B NARASIMHULU [US], et al)
by applicantWO2007131350
 WO2009062285
 WO2009062288
 WO2009062289
 WO2009062308
 WO2010130842
 WO2011076765
 WO2012003497
 WO2012003498
 WO2012033735
 WO2012065963
 WO2012066442
 WO2013012649
 WO2013043553
 WO2013062028
 WO2013073875
 WO2013134113
 WO2013134142
 WO2014021867
 WO2014028384
 WO2014164428
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.